IDH2 and chondrosarcoma: Thus, mutations in Isocitrate Dehydrogenase-1 (IDH1) and -2 (IDH2) are found in 87% of enchondromas, up to 70% of conventional central chondrosarcomas and 54% of dedifferentiated chondrosarcomas and may drive sarcomagenic processes [2,3,4].